Immuneering Corporation (IMRX) Misses Q4 EPS by 13c

Immuneering Corporation (NASDAQ: IMRX) reported Q4 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
• i-80 Gold reports drill results from Nevada mine, delays study timing
• BlackBerry surges on earnings beat and strong cash flow